Release Date: 20/04/15 17:42 Summary: Acitivity Report & Appendix 4C Price Sensitive: Yes Download Document 159.84KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%